Afatinib activity against head-and-neck or esophageal squamous cell carcinoma: Significance of activating oncogenic HER4 mutations in head-and-neck squamous cell carcinoma

被引:0
|
作者
Togashi, Y. [1 ]
Nakamura, Y. [1 ]
Tomida, S. [1 ]
Hayashi, H. [1 ]
de Velasco, M. A. [1 ]
Sakai, K. [1 ]
Fujita, Y. [1 ]
Hamada, S. [2 ]
Nishio, K. [1 ]
机构
[1] Kinki Univ, Sch Med, Dept Genome Biol, Osakasayama, Japan
[2] Kinki Univ, Sch Med, Dept Oral & Maxillofacial Surg, Osakasayama, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
329P
引用
收藏
页码:97 / 97
页数:1
相关论文
共 50 条
  • [1] Afatinib against Esophageal or Head-and-Neck Squamous Cell Carcinoma: Significance of Activating Oncogenic HER4 Mutations in HNSCC
    Nakamura, Yu
    Togashi, Yosuke
    Nakahara, Hirokazu
    Tomida, Shuta
    Banno, Eri
    Terashima, Masato
    Hayashi, Hidetoshi
    de Velasco, Marco A.
    Sakai, Kazuko
    Fujita, Yoshihiko
    Okegawa, Takatsugu
    Nutahara, Kikuo
    Hamada, Suguru
    Nishio, Kazuto
    MOLECULAR CANCER THERAPEUTICS, 2016, 15 (08) : 1988 - 1997
  • [2] Afatinib in squamous cell carcinoma of the head and neck
    Specenier, Pol
    Vermorken, Jan
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (09) : 1295 - 1301
  • [3] The Prognostic Significance of Pretreatment SUV in Head-and-Neck Squamous Cell Carcinoma Treated with IMRT
    Yao, M.
    Lu, M.
    Savvides, P.
    Rezaee, R.
    Bokar, J. A.
    Faulhaber, P. F.
    Lavertu, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S17 - S17
  • [4] Palliative Radiotherapy for Cutaneous Squamous Cell Carcinoma of the Head-and-Neck Region
    Staackmann, Christian
    Schild, Steven E.
    Rades, Dirk
    IN VIVO, 2021, 35 (04): : 2283 - 2288
  • [5] Laminin-γ2 overexpression in head-and-neck squamous cell carcinoma
    Patel, V
    Aldridge, K
    Ensley, JF
    Odell, E
    Boyd, A
    Jones, J
    Gutkind, JS
    Yeudall, WA
    INTERNATIONAL JOURNAL OF CANCER, 2002, 99 (04) : 583 - 588
  • [6] Prognosis classifier for elderly head-and-neck squamous cell carcinoma patients
    Ruehle, A.
    Stromberger, C.
    Haehl, E.
    Senger, C.
    Falkenstein, A. E.
    Stoian, R.
    Zamboglou, C.
    Knopf, A.
    Grosu, A.
    Nicolay, N.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S843 - S843
  • [7] Afatinib in the treatment of head and neck squamous cell carcinoma
    Ferrarotto, Renata
    Gold, Kathryn A.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (01) : 135 - 143
  • [8] Effectiveness of head-and-neck molecular imaging reporting and data system criterion in head-and-neck squamous cell carcinoma postconcurrent chemoradiotherapy
    Gupta, Manoj
    Jajodia, Ankush
    Ahlawat, Parveen
    Gairola, Munish
    Agarwal, Mudit
    Goyal, Sumit
    Mehta, Parv
    Choudhury, Partha
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2023, 38 (04): : 334 - 339
  • [9] Patterns of Failure in Patients With Head-and-Neck Carcinoma of Unknown Primary Treated With Radiation Therapy Definitive Management of Head-and-Neck Squamous Cell Carcinoma
    Cuaron, J.
    Rao, S.
    Wolden, S.
    Zelefsky, M.
    Schupak, K.
    Mychalczak, B.
    Lee, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (02): : 479 - 479
  • [10] Chemoradiation in older head-and-neck squamous cell carcinoma patients - A multicenter analysis
    Ruehle, A.
    Marschner, S.
    Haderlein, M.
    Fabian, A.
    Senger, C.
    Dickstein, D. R.
    Kraft, J.
    Gruen, J. V. D.
    Chen, E.
    Aquino-Michaels, T.
    Domschikowski, J.
    Bickel, A.
    Altay-Langguth, A.
    Lewitzki, V.
    Ferentinos, K.
    Schnellhardt, S.
    Guckenberger, M.
    Budach, V.
    Belka, C.
    Bakst, R.
    Mayer, A.
    Grosu, A.
    Balermpas, P.
    Stromberger, C.
    Nicolay, N. H.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S589 - S589